Why Identifying and Managing Giant Cell Arteritis as an Emergency Is Crucial
Physician's Weekly
JUNE 25, 2025
I’m the Vice Chairman of Rheumatology at the Cleveland Clinic and the co-director of the Center for Vasculitis Care and Research. And I’m here today to talk about giant cell arteritis in clinical practice. Hello everyone. I’m Paras Karmacharya. And RINVOQ is the first oral JAK inhibitor approved for GCA.
59 
Let's personalize your content